期刊文献+

101例儿童急性髓细胞性白血病免疫表型与预后相关分析

Prognostic relevance of immunophenotyping in 101 children with acute myeloid leukemia
下载PDF
导出
摘要 目的探讨免疫表型对儿童急性髓细胞性白血病的预后价值。方法采用流式细胞术检测101例儿童急性髓细胞性白血病(AML)患儿相关免疫表型,分析免疫表型对完全缓解(CR)及无疾病生存期(DFS)的影响。结果CD34阴性组及CD34、HLA-DR同时阴性组一疗程CR率均明显高于非阴性组,差异有统计学意义(P=0.008,0.000);DFS的CD34阴性组,HLA-DR阴性组以及CD34和HLA-DR同时阴性组均明显高于非阴性组,差异有统计学意义(P=0.004,0.006,0.040),而CD14,CD15,CD7,CD19差异对CR和DFS均无统计学意义。结论免疫表型对评估AML患儿的预后有一定意义。 Objective To assess the acute myeloid leukemia (AML). Methods prognostic value of the immunophenotyping in childhood Immunophenotyping was performed in 101 patients by flow cytometry analysis. Results CD34 positive patients had a significantly lower CR rate (P = 0. 008 ), CD34 and HLA-DR both negative had a higher CR rate ( P = 0. 000) ; Duration of disease free survival (DFS) was significantly shorter for patients with CD34 positive (P = 0. 004) or patients with HLA-DR positive (P =0. 006). CD34 and HLA-DR both negative had a longer duration of DFS (P =0. 04). But CD14, CD15, CD7, CD19 were not associated with treatment outcome. Conclusion Immunophenotyping is not only helpful for diagnosis, but can used for a prognostic score.
出处 《中国小儿血液与肿瘤杂志》 CAS 2007年第5期200-203,共4页 Journal of China Pediatric Blood and Cancer
关键词 免疫表型 预后 儿童 白血病 髓细胞性 急性 Immunophenotyping Prognosis Children Acute myeloid leukemia(AML)
  • 相关文献

参考文献3

二级参考文献8

  • 1李娟,顾龙君,薛惠良,汤静燕,陈静,赵惠君,陈静,潘慈,王耀平,叶辉.AML-XH-99方案治疗儿童急性髓系白血病82例疗效分析[J].中华血液学杂志,2004,25(6):351-354. 被引量:21
  • 2刘征辉,张学光,夏学鸣,郑列琳,陆定伟,薛永权,阮长耿.表达CD_7抗原的急性髓细胞白血病[J].中华血液学杂志,1996,17(2):84-84. 被引量:9
  • 3刘征辉,中华血液学杂志,1996年,17卷,84页
  • 4Buckly JD, Lampkin BC, Nesbit ME, et al. Remission induction in children with acute non-lymphocytic leukemia using cytosine arabine and doxorubicin or daunorubicin: a report from the Children's Cancer Study Group. Med Pediatr Oncol, 1989, 17: 382-390.
  • 5Rai KR, Holland JF, Glidewell OJ, et al. Treatment of acute myelocytic leukemia: a study by Cancer and Leukemia Group B. Blood, 1981, 58: 1203-1212.
  • 6Bishop JF, Lowenthal RM, Joshua D, et al. Etoposide in acute nonlymphocytic leukemia. Blood, 1990, 75:27-32.
  • 7Wells RJ, Woods WG, Lampkin BC, et al. Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Childrens Cancer Group. J Clin Oncol, 1993, 11: 538-545.
  • 8Steinbach D, Dorffle W, Eggers G, et al. Improved results in the treatment of acute myeloid leukemia-results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-I-87. Klin Padiatr, 2001, 213: 162-168.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部